These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1423179)

  • 1. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
    Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tumor markers in the management of head and neck cancer.
    Rosati G; Riccardi F; Tucci A
    Int J Biol Markers; 2000; 15(2):179-83. PubMed ID: 10883893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum SCC-Ag in head and neck squamous cell carcinoma.
    Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
    Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.
    Body JJ; Sculier JP; Raymakers N; Paesmans M; Ravez P; Libert P; Richez M; Dabouis G; Lacroix H; Bureau G
    Cancer; 1990 Apr; 65(7):1552-6. PubMed ID: 2311066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck.
    Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J
    Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
    Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
    Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma antigen and protein-bound sialic acid in the management of head and neck cancer.
    Bhatavdekar JM; Patel DD; Vora HH; Balar DB
    Int J Biol Markers; 1991; 6(4):237-40. PubMed ID: 1795131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
    Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
    Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.
    Molina R; Torres MD; Moragas M; Perez-Villa J; Filella X; Jo J; Farrus B; Giménez N; Traserra J; Ballesta AM
    Tumour Biol; 1996; 17(2):81-9. PubMed ID: 8658017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating markers in squamous cell carcinoma of the head and neck: a review.
    Rassekh CH; Johnson JT; Eibling DE
    Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):23-8. PubMed ID: 9135969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of serum markers in the diagnosis and management of laryngeal cancer.
    Mevio E; Benazzo M; Galioto P; Spriano P; Pizzala R
    Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):90-2. PubMed ID: 2032368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase.
    Walther EK; Dahlmann N; Gorgulla HT
    Head Neck; 1993; 15(3):230-5. PubMed ID: 8387981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the usefulness of CYFRA 21-1 as a tumor marker in squamous cell carcinomas of the head and neck].
    Sano K; Kataoka S; Katoh T; Kawauchi H; Morikawa S
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Jul; 100(7):790-7. PubMed ID: 9277101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.